Ima Cor
Medical Devices, 50 Jericho Tpke Ste 105, Jericho, New York, 11753, United States, 11-50 Employees
Phone Number: 51********
Who is IMACOR
ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, d...
Read More
-
Headquarters: 50 Jericho Tpke Ste 105, Jericho, New York, 11753, United States
-
Employees: 11-50
-
Revenue: $10 Million to $25 Million
-
CEO:
Peter Pellerito
Email
Phone
Industry: Medical Devices
SIC Code: 3845
|
NAICS Code: 541618 |
Show More
ImaCor Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding ImaCor
Answer: ImaCor's headquarters are located at 50 Jericho Tpke Ste 105, Jericho, New York, 11753, United States
Answer: ImaCor's phone number is 51********
Answer: ImaCor's official website is https://imacorinc.com
Answer: ImaCor's revenue is $10 Million to $25 Million
Answer: ImaCor's SIC: 3845
Answer: ImaCor's NAICS: 541618
Answer: ImaCor has 11-50 employees
Answer: ImaCor is in Medical Devices
Answer: ImaCor contact info: Phone number: 51******** Website: https://imacorinc.com
Answer: ImaCor designs, manufactures, and distributes hTEE technology, the first and only critical care solution enabling clinicians to optimize cardiac performance with continuously-available, direct cardiac visualization over time, collectively serving patients, clinicians, and hospital administrators with the best possible clinical outcomes and cost-effective resource utilization. hTEE technology is enabled through the EVO ultrasound systems and the miniaturized, disposable ClariTEE probe, uniquely designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. Direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time. Founded in 2004 by two dedicated cardiologists, Scott Roth, M.D. and Steven Evans, M.D., and world-renowned scientist Harold Hastings, Ph.D., ImaCor's vision is that ultrasound-guided hemodynamic management will become the gold standard in advanced hemodynamic management for critical care globally, significantly impacting the quality and economics of patient care. ImaCor's EVO ultrasound systems and ClariTEE probe have been used successfully to provide effective hTEE guidance for thousands of patients worldwide.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month